Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 2 4Phase 2/3 2Phase 1/2 1

Status

Completed 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 4

Conditions

Breast Neoplasms 257Carcinoma, Non-Small-Cell Lung 213Ovarian Neoplasms 134Lung Neoplasms 107Esophageal Neoplasms 69Triple Negative Breast Neoplasms 64Stomach Neoplasms 58Fallopian Tube Neoplasms 56Squamous Cell Carcinoma of Head and Neck 52Neoplasm Metastasis 50Head and Neck Neoplasms 44Esophageal Squamous Cell Carcinoma 43Carcinoma, Ovarian Epithelial 42Neoplasms 36Endometrial Neoplasms 34Uterine Cervical Neoplasms 32Recurrence 29Adenocarcinoma Of Esophagus 24Adenocarcinoma of Lung 22Urinary Bladder Neoplasms 21Melanoma 20Carcinoma, Squamous Cell 19Carcinoma 18Small Cell Lung Carcinoma 17Prostatic Neoplasms 15Breast Neoplasms, Male 15Adenocarcinoma, Bronchiolo-Alveolar 13Peritoneal Neoplasms 12Inflammatory Breast Neoplasms 12Testicular Neoplasms 10

Interventions

Carboplatin 5Trastuzumab 4Paclitaxel 4Cyclophosphamide 3Albumin-Bound Paclitaxel 2130-nm albumin-bound paclitaxel 2pertuzumab 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1Vorinostat 1Thiotepa 1Taxes 1Radiotherapy 1Pharmaceutical Preparations 1Melphalan 1Lapatinib 1Imatinib Mesylate 1Epirubicin 1Drugs, Investigational 1Doxorubicin 1Docetaxel 1Denosumab 1Cryosurgery 1Cisplatin 1Chemotherapy, Adjuvant 1Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Carcinoma, Ductal, Breast × Paclitaxel × Clear all
NCT00295893 2025-09-25

Combination Chemotherapy With or Without Trastuzumab in Treating Patients With Stage II or Stage III Breast Cancer

City of Hope Medical Center

Phase 2 Active not recruiting
121 enrolled 10 charts
Breast

Breast Neoplasms, Carcinoma, Ductal, Breast, Carcinoma, Lobular, Breast Neoplasms, Male, Inflammatory Breast Neoplasms

NCT01891357 2019-09-17

Phase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Breast Cancer

West German Study Group

Phase 2 Terminated
64 enrolled 7 charts
Breast

Carcinoma, Ductal, Breast

NCT00096343 2018-12-04

Paclitaxel and Carboplatin in Treating Women Who Are Undergoing Surgery for Newly Diagnosed, Locally Advanced Breast Cancer

University of Alabama at Birmingham

Phase 2 Completed
31 enrolled
Breast

Breast Neoplasms, Carcinoma, Ductal, Breast, Carcinoma, Lobular, Inflammatory Breast Neoplasms

NCT02199418 2017-01-25

SHPD001

RenJi Hospital

Phase 2 Completed
132 enrolled
Breast

Carcinoma, Ductal, Breast, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡